Skip to main content

Ondansetron

FDA recalls

3 rows

DateCompany and reasonClass
Dec 29, 2025Glenmark Pharmaceuticals Inc., USA
Defective container: Preferred Pharmaceuticals received a letter from the manufacturer Glenmark, that the blister packs are not fully sealed and tablets falling out. Preferred Pharmaceuticals purchased the finished product and repackaged the product for sale.		Class II · Ongoing
Sep 23, 2013Hospira Inc.
Presence of Particular Matter: Potential vendor glass issue - glass spiticules (glass strands) were identified during site inspection of the vials.		Class II · Terminated
May 19, 2013Hospira, Inc.
Presence of Particulate; lot being recalled as a precaution due to the discovery of 2 particles found in a lot which preceded the recalled lot		Class II · Terminated

← Back to Ondansetron

Sources: CMS Medicare Part D Prescribers 2024; CMS Open Payments 2025 (general payments; a payment is not evidence of wrongdoing); FDA enforcement reports (openFDA).